Logo-apb
Adv Pharm Bull. 2024;14(3): 574-590. doi: 10.34172/apb.2024.052
PMID: 39494266        PMCID: PMC11530882

Review Article

Harnessing the Therapeutic Potential of Mesenchymal Stem Cells in Cancer Treatment

Parisa Kangari 1,2 * ORCID, Reza Salahlou 3,4, Somayeh Vandghanooni 2 * ORCID

Cited by CrossRef: 0


1- Radzikowska-Bűchner E, Radej S, Niezabitowska E, Sitarz R, Szewc M. Potential of Using New Indole- and Benzimidazo[1,2-C]quinazolines in Anticancer Therapy Based on Mesenchymal Stem Cells. CMAR. 2025;Volume 17:1087 [Crossref]
2- Gao C, Wang X, Yan H, Zeng G, Chen Y, Gao J. Exosome-Delivered Hsa_Circ_0000116 Facilitates Osteosarcoma Cell Malignancy via PI3K/Akt/mTOR and p38/MAPK Pathways. DNA and Cell Biology. 2025;44(3):153 [Crossref]